Showing 11,401 - 11,420 results of 24,627 for search '(( a step decrease ) OR ( 100 ((we decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.17s Refine Results
  1. 11401

    The effect of estrogen deprivation and estrogen treatment on the growth of BRCA1 antisense and control cells by Lois A Annab (54446)

    Published 2011
    “…</p><p>Copyright © This article is a work of the United States Government and as such must remain in the public domain</p> The mean cell number of BRCA1 pooled population antisense infected cells (filled circle) and vector-only infected cells (white circle) deprived of estrogen for up to 20 days after plating 2.5×10 cells per 100-mm dish. …”
  2. 11402

    HIV-1 and Its gp120 Inhibits the Influenza A(H1N1)pdm09 Life Cycle in an IFITM3-Dependent Fashion by Milene Mesquita (236262)

    Published 2014
    “…The knowledge that HIV-1 changes the host homeostatic equilibrium, which may favor the patient resistance to some co-pathogens, prompted us to investigate whether HIV-1 infection could influence A(H1N1)pdm09 life cycle <i>in vitro</i>. We show here that exposure of A(H1N1)pdm09-infected epithelial cells to HIV-1 viral particles or its gp120 enhanced by 25% the IFITM3 content, resulting in a decrease in influenza replication. …”
  3. 11403

    Table_1_Efficacy and Safety of Complementary Therapy With Jing Si Herbal Tea in Patients With Mild-To-Moderate COVID-19: A Prospective Cohort Study.DOCX by Po-Chun Hsieh (10920474)

    Published 2022
    “…Background<p>Since late 2019, there has been a global COVID-19 pandemic. To preserve medical capacity and decrease adverse health effects, preventing the progression of COVID-19 to severe status is essential. …”
  4. 11404

    Table1_Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements.docx by Alexander Vogt (375813)

    Published 2023
    “…Renal function showed a significant but expected age-associated decrease in the eGFR from 87.8 (IQR: 81.0–100.0) to 72.5 (IQR: 55.8–86.8) ml/min/1.73 m<sup>2</sup> (P < 0.01) in patients with an initial eGFR > 60 ml/min/1.73 m<sup>2</sup>, while a non-significant decrease was observed in patients with an initial eGFR < 60 ml/min/1.73 m<sup>2</sup> at long-term FU [56.0 (IQR: 40.9–58.4) vs. 39.0 (IQR: 13.5–56.3) ml/min/1.73 m<sup>2</sup>].…”
  5. 11405

    Datasheet1_Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements.pdf by Alexander Vogt (375813)

    Published 2023
    “…Renal function showed a significant but expected age-associated decrease in the eGFR from 87.8 (IQR: 81.0–100.0) to 72.5 (IQR: 55.8–86.8) ml/min/1.73 m<sup>2</sup> (P < 0.01) in patients with an initial eGFR > 60 ml/min/1.73 m<sup>2</sup>, while a non-significant decrease was observed in patients with an initial eGFR < 60 ml/min/1.73 m<sup>2</sup> at long-term FU [56.0 (IQR: 40.9–58.4) vs. 39.0 (IQR: 13.5–56.3) ml/min/1.73 m<sup>2</sup>].…”
  6. 11406

    Data_Sheet_1_Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis.docx by Zhou Guan (3723796)

    Published 2021
    “…However, mortality was found significantly decreased in the studies from China (OR = 0.51, 95%CI: 0.39, 0.68; I<sup>2</sup> = 26.50%), while significantly increased outside China (OR = 1.56, 95%CI: 1.12, 2.19; I<sup>2</sup> = 1.00%). …”
  7. 11407

    Supplementary Figure 1 from Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma by Diana Cirstea (48960)

    Published 2023
    “…Transfected cells (IGF1R knock out cells) were cultured with and without AZD8055 100 nM. IGF1R knockout cells show 39% decrease in viability compared to scramble control and the combination of IGF1R knock out and AZD8055 100 nM show a 78% decrease in viability compared to scramble control. …”
  8. 11408

    Supplementary Material for: Dose-dependent relationship between iron metabolism and perioperative myocardial injury in cardiac surgery with cardiopulmonary bypass: A retrospective... by Li Q. (2850350)

    Published 2024
    “…The primary outcome was PMI with a 100x upper reference limit (URL). Results: Of 2420 patients screened,744 eligible patients were enrolled for the final analysis. …”
  9. 11409

    Table1_A Sediment Magnetic Record in the North Pacific Across the Mid-Pleistocene Transition and its Implication on Asian Dust Evolution.XLSX by Ji Young Shin (9136598)

    Published 2021
    “…The detrital magnetic component is characterized by high coercivity (>100 mT) and shows a long-term increase in concentration since ∼1 Ma. …”
  10. 11410

    Image_1_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.jpg by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  11. 11411

    Table_6_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.DOCX by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  12. 11412

    Table_1_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.DOCX by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  13. 11413

    Table_3_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.docx by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  14. 11414

    Image_2_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.jpg by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  15. 11415

    Table_4_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.DOCX by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  16. 11416

    Table_2_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.DOCX by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  17. 11417

    Table_5_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.DOCX by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  18. 11418

    Image_1_Dissociable Effects of Reward on P300 and EEG Spectra Under Conditions of High vs. Low Vigilance During a Selective Visual Attention Task.pdf by Jia Liu (41593)

    Published 2020
    “…To explore the possible differences in the influence of motivation on behavioral performance and neural activity in high and low vigilance levels, we conducted a prolonged 2 h 20 min flanker task and provided monetary rewards during the 20- to 40- and 100- to 120-min intervals of task performance. …”
  19. 11419

    Supplementary Material for: Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropos... by Murt A. (9984845)

    Published 2022
    “…The initial seropositivity rate was 90.9% with inactivated vaccine and 100% with mRNA vaccine. Seropositivity decreased to 44.4% after 6 months, and a booster dose helped in maintaining the 100% of seropositivity (<i>p</i> = 0.005). …”
  20. 11420

    Table_1_Gut Lactobacillus Level Is a Predictive Marker for Coronary Atherosclerotic Lesions Progress and Prognosis in Patients With Acute Coronary Syndrome.docx by Jing Gao (69330)

    Published 2021
    “…After stratifying by the type of ACS, a higher Lactobacillus level was significantly associated with the decreased risks of high SYNTAX score, all-cause death, and MACE in the STEMI subgroup but not in the NSTEMI and UAP subgroups.…”